11 August 2022 · Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
10 August 2022 · Opioid analgesics may be used at any stage of pregnancy at the lowest effective dose for the short-term relief of pain when other analgesics are not effective.
29 June 2022 · Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team